◄ back to all posts

RIOT: Riot Blockchain Inc Stock

Written by | Jul 6, 2018

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 79.10
Enterprise Value ($M) 65.14
Book Value ($M) 33.24
Book Value / Share 0.96
Price / Book 2.38
NCAV ($M) 16.20
NCAV / Share 0.47
Price / NCAV 4.88

Profitability (mra)
Return on Invested Capital (ROIC) -10.40
Return on Assets (ROA) -1.15
Return on Equity (ROE) -1.23

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 6.53

Balance Sheet (mrq) ($M)
Current Assets 20.04
Assets 37.07
Liabilities 3.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 7.85
Operating Income -59.37
Net Income -60.21
Earnings Per Share Basic And Diluted -4.33

Cash Flow Statement (mra) ($M)
Cash From Operations -19.05
Cash from Investing -24.86
Cash from Financing -24.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G/A Citadel Securities GP LLC 1.70
2019-04-18 13G Calc Iii Lp 4.40
2019-02-14 13G/A Susquehanna Securities 3.00
2019-01-31 13G/A Hudson Bay Capital Management LP 2.25
2019-01-31 13G/A Northurst Inc. 0.00
2018-04-19 13D/A Honig Barry C 1.69 -60.29
2018-02-15 13G/A Groussman Mark 1.62
2018-02-13 13G/A Honig Jonathan 1.71 -68.54
2018-02-09 13G/A Peierls E Jeffrey 12.00
2017-04-05 13G/A Remeditex Ventures LLC 0.00 -100.00
2017-01-10 13D/A DeFrancesco Catherine Johanna DeFrancesco 11.45 7.84
2016-09-02 13D/A Mgt Capital Investments Inc 2.12 -92.64
2016-02-01 13G/A Perkins Capital Management Inc 2.90 101.20
2014-02-14 13G/A Flynn James E 2.39

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-07-07 393,753 2,244,000 17.55
2020-07-06 913,774 4,540,700 20.12
2020-07-02 671,180 3,108,600 21.59

(click for more detail)

Similar Companies
RGLS – Regulus Therapeutics Inc. RGNX – REGENXBIO Inc.
RIGL – Rigel Pharmaceuticals, Inc. RLMD – Relmada Therapeutics, Inc.
RLYP – Relypsa, Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

401 K